Stay away from cervical cancer and take the lead in prevention. On January 9, Merck announced a new breakthrough: the second dose schedule (0,6 December) of its 9-valent human papillomavirus vaccine (trade name: Jiadaxiu 9) for 9 14-year-old women has been approved by China's National Medical Products Administration, which has also attracted attention in the industry.
Cervical cancer is a common female malignancy. With the acceleration of China's economic and social development, industrialization and urbanization, and the rapid changes in residents' living environment and lifestyle, the incidence of cervical cancer continues to increase and shows a younger trend. The main cause of cervical cancer is persistent infection with high-risk human papillomavirus (HPV), which can be effectively prevented and eventually eliminated through HPV vaccination for young women, cervical cancer screening in women of appropriate age, and timely cervical cancer and precancerous lesions.
In recent years, various localities have actively promoted the implementation of women's "two cancers" (cervical cancer and breast cancer) screening services, and established a cervical cancer prevention and treatment system with division of labor and cooperation, which has promoted early diagnosis and treatment of cervical cancer, continuously standardized the diagnosis and treatment of cervical cancer, and gradually improved the health awareness of the masses.
For 9 to 14-year-old women in China, the two-dose vaccination procedure of '0,6 December' has simplified the vaccination process and released more vaccine resources, which will further promote the improvement of the vaccination rate of young women in China and help accelerate the elimination of cervical cancer in China. Professor Qiao Youlin from the School of Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, is pleased to see this new vaccination initiative.
Experts recommend that women of appropriate age should be actively vaccinated against HPV and complete the vaccination as recommended by their doctors. In addition, regular cervical cancer screening is also an important means of preventing cervical cancer. Through early detection and abnormal cells, cervical cancer screening can effectively reduce the incidence and mortality of cervical cancer.